“We’re Going to Pray From God That This Does Work”: Trump Keeps Promoting Unproven Drugs

The cocktail carries significant risks and may not fight the coronavirus.

Tasos Katopodis/Getty

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

On Saturday afternoon, President Trump again used the platform of a White House coronavirus briefing to push two unproven drugs as a treatment, feeding into a swirl of medical misinformation and increasing the distance between his ad-hoc views and those of his scientist advisers.

When asked about the anti-malaria drug chloroquine as a possible coronavirus cure, Trump said it, along with the antibiotic azithromycin, could work and suggested they would be shared widely with patients.

“It’s going to be distributed. I think New York is getting 10,000 units,” he said. “We’re going to find out. As the expression goes, ‘What do we have to lose?'”

Trump promoted the drugs at Friday’s briefing and earlier on Saturday morning on Twitter, despite the fact that the Food and Drug Administration has not approved either drug to treat COVID-19, the disease caused by coronavirus. There’s good reason for that. Despite some positive reports stemming from studies with small samples, the untested drug cocktail carries significant risks. As I reported this morning:

When used in conjunction with other medication or in the wrong dosage, taking them can be devastating. In China, officials recommended the use of chloroquine in February after some promising trials, but after a researchers in Wuhan discovered that doubling a daily dose of the drug could lead to death, China quickly “cautioned doctors and health officials about the drug’s lethal side effects and rolled back its usage,” Bloomberg reported. The AFP wire service has reported that social media messages pushing chloroquine have circulated widely in Nigeria, and that health officials there have seen cases of poisoning from the drug. 

Trump seemed unconcerned with these inconvenient details. “This would be a gift from heaven, this would be a gift from God if it works,” he said. “So we’re going to pray from God that it does work.”

When pressed by a reporter about the wisdom of Trump pushing an unverified solution, Vice President Mike Pence said, “There is some anecdotal evidence that several existing medicines may have brought relief to patients struggling in China and Europe.” Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, used that same word—”anecdotal”—to describe the case for a prescription that Trump, only hours prior to briefing, insisted should be “put in use IMMEDIATELY.” 

“The president is talking about hope for people and it’s not an unreasonable thing to hope for people,” Fauci said. “My job as a scientist is to ultimately prove without a doubt that a drug is not only safe but works.”

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate